FrancophonIA/ELRC3.0 huggingface dataset:
English: • hydrolysis by beta-lactamases including (but not limited to) extended-spectrum beta-lactamases (ESBLs), and Amp-C enzymes, that may be induced or stably derepressed in certain aerobic Gramnegative bacterial species;
Maltese: • idrolisi permezz ta' beta-lactamases li tinkludi (iżda mhux limitata għal) beta-lactamases bi spettru estiż (ESBLs - extended-spectrum beta-lactamases), u enzimi Amp-C, li jistgħu jiġu indotti jew imneħħija minn ripressjoni b'mod stabbli f'ċerti speċi ta' batterji aerobiċi negattivi għal Gram;
English: Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, Greece, Hungry, Iceland, Ireland, Lithuania, Luxembourg, Malta, Netherlands, Norway, Poland, Portugal, Romania, Slovenia, Sweden, United Kingdom - Zinacef
Maltese: Il-Belġju, il-Bulgarija, Ċipru, Ir-Repubblika Ċeka , id-Danimarka, l-Estonja, il-Finlandja, il-Greċja, lUngerija, l-Islanda, l-Irlanda, il-Litwanja, il-Lussemburgu, Malta, l-Olanda, in-Norveġja, il-Polonja, ilPortugall, ir-Rumanija, Slovenja, Spanja, l-Isvezja, ir-Renju Unit - Zinacef L-Italja - Curoxim
English: History of severe hypersensitivity (e.g. anaphylactic reaction) to any other type of beta-lactam antibacterial agent (penicillins, monobactams and carbapenems).
Maltese: Storja ta' sensittività eċċessiva qawwija (eż. reazzjoni anafilattika) għal kwalunkwe tip ieħor ta' sustanza antibatterika betalactam (penicillins, monobactams u carbapenems).
English: 0.18% w/v Sodium Chloride plus 4% Dextrose Injection BP 5% Dextrose and 0.9% Sodium Chloride Injection
Maltese: Injezzjoni ta' 0.18% w/v Sodium Chloride flimkien ma' 4% Dextrose BP Injezzjoni ta' 5% Dextrose u 0.9% Sodium Chloride
English: Note3
Maltese: Nota3
English: Concentrations of cefuroxime in excess of the minimum inhibitory levels for common pathogens can be achieved in the tonsilla, sinus tissues, bronchial mucosa, bone, pleural fluid, joint fluid, synovial fluid, interstitial fluid, bile, sputum and aqueous humour.
Maltese: Konċentrazzjonijiet ta' cefuroxime aktar mil-livelli inibitorji minimi għall-patoġeni komuni jistgħu jinkisbu fit-tunsilli, fit-tessuti tas-sinus, fil-mukuża tal-bronki, fl-għadam, fil-fluwidu tal-plewra, filfluwidu tal-ġogi, fil-fluwidu sinovjali, fil-fluwidu tal-interstizju, fil-bajl, fl-isputum u fil-fluwidu akweju talgħajn.
English: Gram-negative aerobes:
Maltese: Aerobi negattivi għal Gram:
English: Belgium, Bulgaria, Cyprus, Czech Republic, Denmark , Estonia, Finland, Greece, Hungry, Iceland, Ireland, Lithuania, Luxembourg, Netherlands, Norway, Poland, Romania, Slovenia, Sweden, United Kingdom - Zinacef
Maltese: Il-Belġju, il-Bulgarija, Ċipru, Ir-Repubblika Ċeka , id-Danimarka, l-Estonja, il-Finlandja, il-Greċja, lUngerija, l-Islanda, l-Irlanda, il-Litwanja, il-Lussemburgu, l-Olanda, in-Norveġja, il-Polonja, il-Portugall, irRumanija, Slovenja, Spanja, l-Isvezja, ir-Renju Unit - Zinacef Franza - Zinnat
English: Surgical prophylaxis for gastrointestinal, gynaecological surgery (including caesarean section) and orthopaedic operations
Maltese: Profilassi kirurġika għal operazzjonijiet gastrointestinali, ġinekoloġiċi (inkluż ċesarja) u ortopediċi
English: Sodium Chloride Injection BP 0.9% w/v
Maltese: Injezzjoni ta' 0.9% w/v Sodium Chloride BP
English: Denmark, Finland, Greece, Hungry, Ireland, Lithuania, Malta, Netherlands, Norway, Poland, Sweden, United Kingdom - Zinacef
Maltese: Id-Danimarka, il-Finlandja, il-Greċja, l-Ungerija, l-Irlanda, il-Litwanja, Malta, l-Olanda, in-Norveġja, ilPolonja, Spanja, l-Isvezja, ir-Renju Unit - Zinacef
English: Austria - Curocef
Maltese: L-Awstrija - Curocef
English: • bacterial efflux pumps.
Maltese: • pompi ta' effluss tal-batterji.
English: PHARMACEUTICAL PARTICULARS 6.1 List of excipients [To be completed nationally] 6.2 Incompatibilities [To be completed nationally] 6.3 Shelf life
Maltese: FARMAĊEWTIKU 6.1 Lista ta' eċċipjenti [Biex timtela mill-pajjiż partikolari] 6.2 Inkompatibbilitajiet [Biex timtela mill-pajjiż partikolari] 6.3 Żmien kemm idum tajjeb il-prodott mediċinali [Biex timtela mill-pajjiż partikolari] 6.4
English: 1 The cephalosporin breakpoints for Enterobacteriaceae will detect all clinically important resistance mechanisms (including ESBL and plasmid mediated AmpC).
Maltese: 1Il-breakpoints tas-cephalosporin għal Enterobacteriaceae jistgħu jinnutaw il-mekkaniżmi kollha ta' reżistenza klinikament importanti (inkluż ESBL u AmpC medjat mill-plażmid).
English: • reduced affinity of penicillin-binding proteins for cefuroxime;
Maltese: • tnaqqis fl-affinità tal-proteini li jorbtu magħhom il-penicillin għal cefuroxime;
English: Blood and lymphatic system disorders neutropenia, eosinophilia, decreased haemoglobin concentration leukopenia, positive Coomb's test thrombocytopenia, haemolytic anaemia
Maltese: Disturbi tad-demm u tas-sistema limfatika newtropenija, eosinofilja, tnaqqis filkonċentrazzjoni talemoglobin lewkopenija, riżultat pożittiv għat-test ta' Coombs tromboċitopenija, anemija emolitika
English: • to prevent infections during surgery.
Maltese: • biex jilqa' kontra infezzjonijiet waqt operazzjoni.
English: After intramuscular (IM) injection of cefuroxime to normal volunteers, the mean peak serum concentrations ranged from 27 to 35 µg/mL for a 750 mg dose and from 33 to 40 µg/mL for a 1000 mg dose, and were achieved within 30 to 60 minutes after administration.
Maltese: Wara injezzjoni ta' cefuroxime ġol-muskolu (IM) lill-voluntiera normali, il-medja tal-ogħla konċentrazzjonijiet fis-serum kienet tvarja minn 27 sa 35 µg/mL għal doża ta' 750 mg u minn 33 sa 40 µg/mL għal doża ta' 1000 mg, u nkisbet fi żmien 30 sa 60 minuta wara l-għoti.
English: Skin and subcutaneous tissue disorders skin rash, urticaria and pruritus erythema multiforme, toxic epidermal necrolysis and StevensJohnson syndrome, angioneurotic oedema
Maltese: Disturbi fil-ġilda u fit-tessut ta' taħt ilġilda raxx fil-ġilda, urikarja u ħakk eritema multiforme, nekroliżi tossika tal-epidermide u sindrome ta' Stevens-Johnson, edima anġionewrotika
English: Cefuroxime sodium (5 mg/ml) in 5% w/v or 10% w/v xylitol injection may be stored for up to 24 h at 25oC.
Maltese: Cefuroxime sodium (5 mg/ml) f'injezzjoni ta' xylitol 5% w/v jew10% w/v jista' jinħażen sa 24 siegħa f'temperatura ta' 25oC.
English: Following intravenous (IV) doses of 750 and 1500 mg, serum concentrations were approximately 50 and 100 µg/mL, respectively, at 15 minutes.
Maltese: Wara dożi ta' 750 u 1500 mg fil-vina (IV), il-konċentrazzjonijiet fis-serum kienu madwar 50 u 100 µg/mL, rispettivament, fil15-il minuta.
English: Repeat steps 4 to 6 to rinse the inside of the vial.
Maltese: Irrepeti l-passi 4 sa 6 biex tlaħlaħ ġewwa tal-kunjett.
English: • injection site pain, swelling and redness along a vein.
Maltese: • Infezzjonijiet fit-tessuti rotob: ċellulite, irsipla u infezzjonijiet fil-ġrieħi.
English: 500 mg powder for solution for injection 500 mg intramuscular
Maltese: 500 mg trab għal soluzzjoni għall-injezzjoni 500 mg intramuskolari
English: General disorders and administration site conditions injection site reactions which may include pain and thrombophlebitis Description of selected adverse reactions Cephalosporins as a class tend to be absorbed onto the surface of red cell membranes and react with antibodies directed against the drug to produce a positive Coomb's test (which can interfere with cross matching of blood) and very rarely haemolytic anaemia.
Maltese: Bħala klassi s-cephalosporins għandhom tendenza li jiġu assorbiti fuq is-superfiċje tal-membrana taċ-ċelluli l-ħomor u jirreaġixxu ma' antikorpi immirati kontra l-mediċina biex jipproduċu riżultat pożittiv fit-test ta' Coombs (li jista' jfixkel it-tqabbil inkroċjat tad-demm) u b'mod rari ħafna anemija emolitika.
English: However, in older infants (aged >3 weeks) and in children, the serum half-life of 60 to 90 minutes is similar to that observed in adults.
Maltese: Madankollu, fi trabi akbar (li għandhom >3 ġimgħat) u fit-tfal, il-half-life ta' 60 sa 90 minuta tixbah lil dik osservata fl-adulti.
English: Inherently resistant microorganisms Gram-positive aerobes:
Maltese: Mikroorganiżmi reżistenti b'mod inerenti Aerobi pożittivi għal Gram:
English: Overdose can lead to neurological sequelae including encephalopathy, convulsions and coma.
Maltese: Doża eċċessiva tista' twassal għal konsegwenzi newroloġiċi inkluż enċefalopatija, konvulżjonijiet u koma.
English: Peptostreptococcus spp.
Maltese: L-ispeċijiet Peptostreptococcus
English: The average renal clearance ranges from 114 to 170 mL/min/1.73 m2 following IM or IV administration over the dosage range of 250 to 1000 mg.
Maltese: It-tneħħija medja ta' cefuroxime mill-kliewi tvarja minn 114 sa 170 mL/min/1.73 m2 wara għoti minn fil-muskolu jew minn fil-vina fuq medda ta' doża ta' bejn 250 u 1000 mg.
English: It is not necessary to reduce the standard dose (750 mg to 1.5 g three times daily).
Maltese: Mhuwiex meħtieġ li d-doża standard titnaqqas (750 mg sa 1.5 g tliet darbiet kuljum).
English: Candida overgrowth, overgrowth of Clostridium difficile
Maltese: Infezzjonijiet u infestazzjonijiet tkabbir żejjed ta' Candida, tkabbir żejjed ta' Clostridium difficile
English: 750 mg Monovial powder for solution for infusion Italy - Curoxim
Maltese: 750 mg kunjett għal użu wieħed trab għal soluzzjoni għall-infużjoni L-Italja - Curoxim Monovial
English: 1.5 g cefuroxime sodium constituted with 15 mL Water for Injection may be added to metronidazole injection (500 mg/100 ml) and both retain their activity for up to 24 hours below 25 oC. 1.5 g cefuroxime sodium is compatible with azlocillin 1 g (in 15 ml) or 5 g (in 50 ml) for up to 24 h at 4oC or 6 h below 25oC.
Maltese: 1.5 g ta' cefuroxime sodium ikkostitwit bi 15-il mL ta' Ilma għall-Injezzjoni jista' jiżdied ma' injezzjoni ta' metronidazole (500 mg/100 ml) u t-tnejn li huma jżommu l-attività tagħhom sa 24 siegħa f'temperatura taħt il-25 oC.
English: There was no evidence of accumulation of cefuroxime in the serum from normal volunteers following repeat intravenous administration of 1500 mg doses every 8 hours.
Maltese: Ma kien hemm l-ebda evidenza ta' akkumulazzjoni ta' cefuroxime mis-serum ta' voluntiera normali wara għoti ta' dożi ripetuti ta' 1500 mg kull 8 sigħat fil-vini.
English: No differences in the pharmacokinetics of cefuroxime were observed between males and females following a single IV bolus injection of 1000 mg of cefuroxime as the sodium salt.
Maltese: Ma kienet osservata l-ebda differenza fil-farmakokinetika ta' cefuroxime bejn l-irġiel u n-nisa wara injezzjoni singola ta' 1000 mg ta' cefuroxime bħala sodium salt f'daqqa ġol-vina.
English: Cefuroxime inhibits bacterial cell wall synthesis following attachment to penicillin binding proteins (PBPs).
Maltese: Cefuroxime jimpedixxi s-sintesi tas-superfiċje taċ-ċellula tal-batterju wara li jeħel mal-proteini li jorbtu magħhom il-peniċillin (PBPs - penicillin binding proteins).
English: • the abdomen
Maltese: • tal-addome
English: Hepatic impairment
Maltese: Infezzjonijiet qawwija
English: • outer membrane impermeability, which restricts access of cefuroxime to penicillin binding proteins in Gram-negative bacteria;
Maltese: • impermeabilità tal-membrana ta' barra, li tillimita l-aċċess ta' cefuroxime għall-proteini li jorbtu magħhom il-penicillin f'batterji negattivi għal Gram;
English: 1 mL at least 2 mL
Maltese: 1 mL mill-inqas 2 mL
English: cardiovascular, and gynaecological surgery (including caesarean section).
Maltese: kardjovaskulari, u ġinekoloġiċi (inkluż ċesarja).
English: 1.5 g every 8 hours (intravenously or intramuscularly)
Maltese: 1.5 g kull 8 sigħat ((ġol-vini jew intramuskolari)
English: Zinacef is usually be given by a doctor or nurse.
Maltese: Zinacef is-soltu jigħata minn tabib jew infermier.
English: Zinacef is indicated for the treatment of the infections listed below in adults and children, including neonates (from birth) (see sections 4.4 and 5.1).
Maltese: Zinacef huwa indikat għall-kura tal-infezzjonijiet elenkati hawn taħt f'adulti u fi tfal, inkluż trabi tat-twelid (mit-twelid) (ara sezzjonijiet 4.4 u 5.1).
English: Compatibility
Maltese: Kumpatibbiltà
English: • Complicated urinary tract infections, including pyelonephritis.
Maltese: • Infezzjonijiet ikkumplikati fl-apparat tal-awrina, inkluż pajelonefrite.
English: Microorganisms for which acquired resistance may be a problem Gram-positive aerobes:
Maltese: Mikroorganiżmi li jista' jkollhom il-problema li jiksbu reżistenza Aerobi pożittivi għal Gram:
English: Cefuroxime sodium is compatible with the following infusion fluids.
Maltese: Cefuroxime sodium huwa kumpatibbli mal-fluwidi tal-infużjoni li ġejjin.
English: Minimum inhibitory concentration (MIC) breakpoints established by the European Committee on Antimicrobial Susceptibility Testing (EUCAST) are as follows:
Maltese: Il-breakpoints tal-konċentrazzjoni inibitorja minima (MIC- minimum inhibitory concentration) stabbiliti mill-Kumitat Ewropew dwar l-Ittestjar ta' Suxxettibilità Kontra l-Mikrobi (EUCAST - European Committee on Antimicrobial Susceptibility Testing) huma kif ġej:
English: This may have significance in the interference in clinical laboratory tests in humans.
Maltese: Dan jista' jkollu importanza fl-interferenza ma' testijiet kliniċi tal-laboratorju fil-bnedmin.
English: The stability of cefuroxime sodium in Sodium Chloride Injection BP 0.9% w/v and in 5% Dextrose Injection is not affected by the presence of hydrocortisone sodium phosphate.
Maltese: L-istabbilità ta' cefuroxime sodium f'Injezzjoni ta' 0.9% Sodium Chloride BP w/v u f'Injezzjoni ta' 5% Dextrose mhijiex affettwata mill-preżenza ta' hydrocortisone sodium phosphate.
English: A further 750 mg dose should be given intravenously or intramuscularly at the end of each dialysis; in addition to parenteral use, cefuroxime sodium can be incorporated into the peritoneal dialysis fluid (usually 250 mg for every 2 litres of dialysis fluid).
Maltese: Doża oħra ta' 750 mg għandha tingħata ġolvini jew ġol-muskoli fl-aħħar ta' kull sessjoni tad-dijalisi; flimkien mal-użu b'mod parenterali, cefuroxime sodium jista' jiġi inkorporat mal-fluwidu tad-dijalisi millperitonew (ġeneralment 250 mg għal kull 2 litri ta' fluwidu tad-dijalisi).
English: Note4
Maltese: Nota4
English: 2 g powder for solution for infusion 2 g intravenous infusion
Maltese: 2 g trab għal soluzzjoni għall-infużjoni 2 g infużjoni ġol
English: Zinacef is also used:
Maltese: Inti m'għandekx tingħata Zinacef:
English: • water tablets (diuretics), such as furosemide
Maltese: • pinnoli tal-pipi (dijuretiċi), bħal ma hu furosemide
English: Infants and toddlers > 3 weeks and children < 40 kg
Maltese: Trabi u tfal żgħar > 3 ġimgħat u tfal < 40 kg
English: at least 6 mL at least 6 mL
Maltese: mill-inqas 6 mL mill-inqas 6 mL
English: Zinacef strength
Maltese: X'fih Zinacef
English: Zinacef 250 mg , 750 mg and 1.5 g powder for solution for injection; Zinacef 250 mg, 750 mg and 1.5 g powder for solution for injection or infusion IM/IV.
Maltese: Zinacef 250 mg, 750 mg u 1.5 g trab għal soluzzjoni għall-injezzjoni; Zinacef 250 mg, 750 mg u 1.5 g trab għal soluzzjoni għall-injezzjoni jew għall-infużjoni IM/IV
English: 750 mg every 8 hours (intravenously or intramuscularly)
Maltese: 750 mg kull 8 sigħat (ġol-vini jew intramuskolari)
English: Concomitant use with oral anticoagulants may give rise to increased international normalised ratio (INR).
Maltese: L-użi flimkien ma' antikoagulanti mill-ħalq jista' jwassal għal żieda fil-proporzjon internazzjonali normalizzat (INR- international normalised ratio).
English: For cephalosporins, the most important pharmacokinetic-pharmacodynamic index correlating with in vivo efficacy has been shown to be the percentage of the dosing interval (%T) that the unbound concentration remains above the minimum inhibitory concentration (MIC) of cefuroxime for individual target species (i.e. %T>MIC).
Maltese: Għas-cephalosporins, l-indiċi farmakokinetiku-farmakodinamiku l-aktar importanti li jaqbel mal-effikaċja in vivo intwera li huwa l-perċentwal tal-ħin ta' bejn doża u oħra (%T) li fih il-konċentrazzjoni ta' cefuroxime mhux marbut tibqa' ogħla mill-konċentrazzjoni inibitorja minima (MIC) għall-ispeċi individwali fil-mira (i.e.%T>MIC).
English: Hypersensitivity to cefuroxime or to any of the excipients listed in section 6.1.
Maltese: Sensittività eċċessiva għal cefuroxime jew għal kwalunkwe wieћed mill-eċċipjenti elenkati fis-sezzjoni 6.1.
English: Newborn babies (0 - 3 weeks)
Maltese: Trabi tat-twelid (0-3 ġimgħat)
English: Zinacef 750 mg, 1.5 g and 2 g powder for solution for infusion IV
Maltese: Zinacef 750 mg, 1.5 g u 2 g trab għal soluzzjoni għall-infużjoni IV
English: • aminoglycoside-type antibiotics
Maltese: • antikoagulanti mill-ħalq
English: Patients in renal failure on continuous arteriovenous haemodialysis (CAVH) or high-flux haemofiltration (HF) in intensive therapy units
Maltese: Pazjenti b'insuffiċjenza tal-kliewi li qegħdin fuq dijalisi arterjovenuża kontinwa tad-demm (CAVH continuous arteriovenous haemodialysis) jew filtrazzjoni taddemm b'membrana bil-pori kbar (HF high-flux haemofiltration) f'oqsma talkura intensiva
English: Symptoms of overdose can occur if the dose is not reduced appropriately in patients with renal impairment (see sections 4.2 and 4.4).
Maltese: Sintomi ta' doża eċċessiva jistgħu jseħħu jekk id-doża ma titnaqqasx b'mod xieraq f'pazjenti b'indeboliment tal-kliewi (ara sezzjonijiet 4.2 u 4.4).
English: Zinacef 250 mg, 500 mg, 750 mg and 1 g powder and solvent for solution for injection IM/IV
Maltese: Zinacef 250 mg, 500 mg, 750 mg, u 1 g trab u solvent għal soluzzjoni għall-injezzjoni IM/IV
English: Zinacef is an antibiotic used in adults and children.
Maltese: Zinnat huwa antibijotiku użat fl-adulti u fit-tfal.
English: Zinacef and associated names (see Annex I) 250 mg powder for solution for injection
Maltese: Zinacef u ismijiet assoċjati (ara Anness I) 250 mg trab għal soluzzjoni għall-injezzjoni
English: Renal and urinary disorders elevations in serum creatinine, elevations in blood urea nitrogen and decreased creatinine clearance (see section 4.4)
Maltese: Disturbi fil-kliewi u fis-sistema urinarja żidiet tal-krejatinina fis-serum, żidiet tan-nitroġenu mill-urea fiddemm u tnaqqis fit-tneħħija talkrejatinina (ara sezzjoni 4.4)
English: Bacteroides spp.
Maltese: Bacteroides fragilis
English: 250 mg powder for solution for injection 250 mg intramuscular intravenous
Maltese: 250 mg trab għal soluzzjoni għall-injezzjoni 250 mg intramuskolari ġol-vini
English: 30 to 100 mg/kg/day (intravenously) given as 3 or 4 divided doses; a dose of 60 mg/kg/day is appropriate for most infections
Maltese: 30 sa 100 mg/kg/jum (ġol-vini) tingħata maqsuma fi 3 jew 4 dożi; doża ta' 60 mg/kg/jum hija xierqa għall-biċċa l-kbira tal-infezzjonijiet
English: As a false negative result may occur in the ferricyanide test, it is recommended that either the glucose oxidase or hexokinase methods are used to determine blood/plasma glucose levels in patients receiving cefuroxime sodium.
Maltese: Minħabba li jista' joħroġ riżultat negattiv falz fit-test tal-ferricyanide, huwa rrakkomandat li jintużaw ilmetodi ta' glucose oxidase jew ta' hexokinase biex jiġu ddeterminati l-livelli ta' glucose fid-demm/filplażma ta' pazjenti li jkunu qed jieħdu cefuroxime sodium.
English: 1.5 g powder for solution for injection or infusion 1.5 g intramuscular intravenous bolus intravenous infusion
Maltese: 1.5 g trab għal soluzzjoni għall-injezzjoni jew għall-infużjoni 1.5 g intramuskolari doża f'daqqa għal ġol-vini infużjoni ġol-vini
English: Mycoplasma spp.
Maltese: L-ispeċijiet Mycoplasma
English: 1.5 g with induction of anaesthesia followed by 750 mg (intramuscularly) every 8 hours for a further 24 hours.
Maltese: 1.5 g mal-ikkaġunar tal-anestesija segwita minn 750 mg (intramuskolari) kull 8 sigħat għal 24 siegħa oħra.
English: Zinacef should be administered by intravenous injection over a period of 3 to 5 minutes directly into a vein or via a drip tube or infusion over 30 to 60 minutes, or by deep intramuscular injection.
Maltese: Zinacef għandu jingħata permezz ta' injezzjoni fil-vini fuq perjodu ta' bejn 3 u 5 minuti direttament ġo vina jew permezz ta' tubu tad-dripp jew infużjoni fuq perjodu ta' bejn 30 u 60 minuta, jew permezz ta' injezzjoni fil-fond ġol-muskolu.
English: In vitro the activities of cefuroxime sodium and aminoglycoside antibiotics in combination have been shown to be at least additive with occasional evidence of synergy.
Maltese: In vitro l-attivitajiet ta' cefuroxime sodium u l-antibijotiċi aminoglycoside flimkien intwerew li tal-anqas kienu addittivi b'evidenza ta' sinerġija xi kultant.
English: * Reconstituted solution to be added to 50 or 100 ml of compatible infusion fluid (see information on compatibility, below)
Maltese: * Is-soluzzjoni rriskostitwita għandha tiżdied ma' 50 jew 100 ml ta' fluwidu kumpatibbli tal-infużjoni (ara informazzjoni fuq il-kompatibbiltà, hawn taħt)
English: 750 mg every 6 hours (intravenously) 1.5 g every 8 hours (intravenously)
Maltese: 750 mg kull 6 sigħat (ġol-vini) 1.5 g kull 8 sigħat (ġol-vini)
English: Propionibacterium spp.
Maltese: L-ispeċijiet Propionibacterium
English: • low levels of red blood cells (anaemia)
Maltese: • livelli baxxi ta' ċelluli ħomor tad-demm (anemija)
English: 5 Breakpoints apply to daily intravenous dose of 750 mg × 3 and a high dose of at least 1.5 g × 3.
Maltese: Il-breakpoints japplikaw għal doża ta' 750 mg × 3 mill-vina u doża għolja ta' mill-anqas 1.5 g × 3.
English: Complicated urinary tract infections, including pyelonephritis
Maltese: Infezzjonijiet ikkumplikati fl-apparat talawrina, inkluż pajelonefrite
English: Interference with diagnostic tests
Maltese: DATA TA' REVIŻJONI TAT-TEST
English: • skin rash, itchy, bumpy rash (hives)
Maltese: • raxx fil-ġilda, raxx bil-ħakk u mqabbeż (ħorriqija)
English: Because elderly patients are more likely to have decreased renal function, care should be taken in cefuroxime dose selection, and it may be useful to monitor renal function (see section 4.2).
Maltese: Minħabba li pazjenti anzjani għandhom aktar mnejn ikollhom tnaqqis fil-funzjoni tal-kliewi, għandu jkun hemm attenzjoni fl-għażla tad-doża ta' cefuroxime, u jista' jkun ta' siwi li tiġi mmonitorjata l-funzjoni tal-kliewi (ara sezzjoni 4.2).
English: Zinacef can affect the results of urine or blood tests for sugar and a blood test known as the Coombs test.
Maltese: Zinacef jista' jaffettwa ir-riżultati ta' testijiet tal-awrina jew tad-demm għaz-zokkor u test tad-demm magħruf bħala t-test ta' Coombs.
English: Due to its spectrum of activity, cefuroxime is not suitable for the treatment of infections caused by Gramnegative non-fermenting bacteria (see section 5.1).
Maltese: Minħabba l-ispettru ta' attività tiegħu, cefuroxime mhuwiex adattat għall-kura ta' infezzjonijiet ikkawżati minn batterji negattivi għal Gram li ma jikkawżawx fermentazzjoni (ara sezzjoni 5.1).
English: Gamma glutamyl transpeptidase activity in rat urine is inhibited by various cephalosporins, however the level of inhibition is less with cefuroxime.
Maltese: L-attività ta' gamma glutamyl transpeptidase fl-awrina tal-far hija impedita minn ħafna cepahlosporins, madankollu l-livell ta' inibizzjoni huwa anqas b'cefuroxime.
English: 750 mg twice daily; for low-flux haemofiltration follow the dosage recommended under impaired renal function.
Maltese: 750 mg darbtejn kuljum; għal filtrazzjoni taddemm b'membrana bil-pori żgħar segwi d-doża rrakkomandata taħt funzjoni indebolita talkliewi.
English: 250 mg, 500 mg, 750 mg, 1 g powder and solvent for solution for injection Powder and solvent for solution for injection [To be completed nationally]
Maltese: 250 mg, 500 mg, 750 mg, 1 g trab u solvent għal soluzzjoni għall-injezzjoni Trab u solvent għal soluzzjoni għall-injezzjoni [Biex timtela mill-pajjiż partikolari]
English: Some medicines may affect how Zinacef works, or make it more likely that you'll have side effects.
Maltese: Xi mediċini jistgħu jaffettwaw kif jaħdem Zinacef, jew iżidu l-probabbiltà li jkollok effetti sekondarji.
English: Zinacef 250 mg, 500 mg, 750 mg and 1 g powder and solvent for solution for injection Intramuscular or intravenous use.
Maltese: Zinacef 250 mg, 500 mg, 750 mg u 1 g trab u solvent għal soluzzjoni għall-injezzjoni